UBS analyst Karl Keirstead lowered the firm’s price target on DocuSign (DOCU) to $80 from $85 and keeps a Neutral rating on the shares.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DOCU:
- DocuSign price target lowered to $85 from $93 at Baird
- DocuSign price target lowered to $86 from $92 at Morgan Stanley
- DocuSign’s Transitional Challenges and Strategic Investments Lead to Hold Rating
- DocuSign price target raised to $67 from $65 at Wells Fargo
- DocuSign’s Strategic Shift and Macroeconomic Challenges Lead to Hold Rating